Alliancebernstein L.P. Kala Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $16,710 - $72,967	-55,700 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.61 - $1.84 $13,054 - $39,376	-21,400 Reduced 27.76%	55,700 $77,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $10,208 - $24,112	-8,800 Reduced 10.24%	77,100 $93,000
Q2 2021 Jul 30, 2021	BUY	$5.06 - $8.15 $219,603 - $353,710	43,400 Added 102.12%	85,900 $455,000
Q1 2021 May 06, 2021	SELL	$6.24 - $9.58 $106,704 - $163,818	-17,100 Reduced 28.69%	42,500 $286,000

Q4 2020 Feb 08, 2021	BUY	$6.28 - $8.79 $5,652 - $7,910	900 Added 1.53%	59,600 $404,000
Q2 2020 Aug 13, 2020	BUY	$8.33 - $13.79 $127,449 - $210,987	15,300 Added 35.25%	58,700 $617,000
Q1 2020 May 14, 2020	BUY	$3.83 - $8.79 $106,091 - $243,482	27,700 Added 176.43%	43,400 $381,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $8.8 $77,401 - $138,160	15,700 New	15,700 $100,000
Q4 2017 Feb 13, 2018	SELL	$13.68 - $23.17 $273,600 - $463,400	-20,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$19.86 - $26.53 $397,200 - $530,600	20,000	20,000 $457,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.